Heike A Bischoff-Ferrari1,2,3, Bruno Vellas4,5, René Rizzoli6, Reto W Kressig7, José A P da Silva8,9, Michael Blauth10, David T Felson11,12, Eugene V McCloskey13,14, Bernhard Watzl15, Lorenz C Hofbauer16,17, Dieter Felsenberg18, Walter C Willett19,20, Bess Dawson-Hughes21, JoAnn E Manson22, Uwe Siebert23,24,25, Robert Theiler2, Hannes B Staehelin26, Caroline de Godoi Rezende Costa Molino1, Patricia O Chocano-Bedoya1, Lauren A Abderhalden1, Andreas Egli1, John A Kanis27,28, Endel J Orav29. 1. Center on Aging and Mobility, University Hospital Zurich, City Hospital Waid & Triemli and University of Zurich, Zurich, Switzerland. 2. Department of Geriatric Medicine and Aging Research, University Hospital Zurich and University of Zurich, Zurich, Switzerland. 3. University Clinic for Acute Geriatric Care, City Hospital Waid & Triemli, Zurich, Switzerland. 4. Gérontopôle de Toulouse, Institut du Vieillissement, Center Hospitalo-Universitaire de Toulouse, Toulouse, France. 5. UMR INSERM 1027, University of Toulouse III, Toulouse, France. 6. Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland. 7. University Department of Geriatric Medicine Felix Platter and University of Basel, Basel, Switzerland. 8. Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. 9. Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal. 10. Department for Trauma Surgery, Medical University of Innsbruck, Innsbruck, Austria. 11. NIHR Manchester Biomedical Research Center, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center, Manchester, England. 12. Rheumatology, Boston University School of Medicine, Boston, Massachusetts. 13. MRC Arthritis Research UK Center for Integrated Research Into Musculoskeletal Ageing, University of Sheffield, Sheffield, England. 14. Academic Unit of Bone Metabolism, Department of Oncology and Metabolism, The Mellanby Center for Bone Research, University of Sheffield, Sheffield, England. 15. Department of Physiology and Biochemistry of Nutrition, Max Rubner-Institut, Karlsruhe, Germany. 16. Center for Healthy Aging, Department of Medicine III Dresden University Medical Center, Dresden, Germany. 17. Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany. 18. Center for Muscle and Bone Research, Department of Radiology, Charité Universitätsmedizin Berlin, Berlin, Germany. 19. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 20. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 21. Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts. 22. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 23. Department of Public Health, Health Services Research, and Health Technology Assessment, UMIT-University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria. 24. Center for Health Decision Science, Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 25. Program on Cardiovascular Research, Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston. 26. Department of Geriatrics, University of Basel, Basel, Switzerland. 27. Center for Metabolic Diseases, University of Sheffield Medical School, Sheffield, England. 28. Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia. 29. Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
Abstract
Importance: The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention remain unclear. Objective: To test whether vitamin D, omega-3s, and a strength-training exercise program, alone or in combination, improved 6 health outcomes among older adults. Design, Setting, and Participants: Double-blind, placebo-controlled, 2 × 2 × 2 factorial randomized clinical trial among 2157 adults aged 70 years or older who had no major health events in the 5 years prior to enrollment and had sufficient mobility and good cognitive status. Patients were recruited between December 2012 and November 2014, and final follow-up was in November 2017. Interventions: Participants were randomized to 3 years of intervention in 1 of the following 8 groups: 2000 IU/d of vitamin D3, 1 g/d of omega-3s, and a strength-training exercise program (n = 264); vitamin D3 and omega-3s (n = 265); vitamin D3 and exercise (n = 275); vitamin D3 alone (n = 272); omega-3s and exercise (n = 275); omega-3s alone (n = 269); exercise alone (n = 267); or placebo (n = 270). Main Outcomes and Measures: The 6 primary outcomes were change in systolic and diastolic blood pressure (BP), Short Physical Performance Battery (SPPB), Montreal Cognitive Assessment (MoCA), and incidence rates (IRs) of nonvertebral fractures and infections over 3 years. Based on multiple comparisons of 6 primary end points, 99% confidence intervals are presented and P < .01 was required for statistical significance. Results: Among 2157 randomized participants (mean age, 74.9 years; 61.7% women), 1900 (88%) completed the study. Median follow-up was 2.99 years. Overall, there were no statistically significant benefits of any intervention individually or in combination for the 6 end points at 3 years. For instance, the differences in mean change in systolic BP with vitamin D vs no vitamin D and with omega-3s vs no omega-3s were both -0.8 (99% CI, -2.1 to 0.5) mm Hg, with P < .13 and P < .11, respectively; the difference in mean change in diastolic BP with omega-3s vs no omega-3s was -0.5 (99% CI, -1.2 to 0.2) mm Hg; P = .06); and the difference in mean change in IR of infections with omega-3s vs no omega-3s was -0.13 (99% CI, -0.23 to -0.03), with an IR ratio of 0.89 (99% CI, 0.78-1.01; P = .02). No effects were found on the outcomes of SPPB, MoCA, and incidence of nonvertebral fractures). A total of 25 deaths were reported, with similar numbers in all treatment groups. Conclusions and Relevance: Among adults without major comorbidities aged 70 years or older, treatment with vitamin D3, omega-3s, or a strength-training exercise program did not result in statistically significant differences in improvement in systolic or diastolic blood pressure, nonvertebral fractures, physical performance, infection rates, or cognitive function. These findings do not support the effectiveness of these 3 interventions for these clinical outcomes. Trial Registration: ClinicalTrials.gov Identifier: NCT01745263.
Importance: The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention remain unclear. Objective: To test whether vitamin D, omega-3s, and a strength-training exercise program, alone or in combination, improved 6 health outcomes among older adults. Design, Setting, and Participants: Double-blind, placebo-controlled, 2 × 2 × 2 factorial randomized clinical trial among 2157 adults aged 70 years or older who had no major health events in the 5 years prior to enrollment and had sufficient mobility and good cognitive status. Patients were recruited between December 2012 and November 2014, and final follow-up was in November 2017. Interventions: Participants were randomized to 3 years of intervention in 1 of the following 8 groups: 2000 IU/d of vitamin D3, 1 g/d of omega-3s, and a strength-training exercise program (n = 264); vitamin D3 and omega-3s (n = 265); vitamin D3 and exercise (n = 275); vitamin D3 alone (n = 272); omega-3s and exercise (n = 275); omega-3s alone (n = 269); exercise alone (n = 267); or placebo (n = 270). Main Outcomes and Measures: The 6 primary outcomes were change in systolic and diastolic blood pressure (BP), Short Physical Performance Battery (SPPB), Montreal Cognitive Assessment (MoCA), and incidence rates (IRs) of nonvertebral fractures and infections over 3 years. Based on multiple comparisons of 6 primary end points, 99% confidence intervals are presented and P < .01 was required for statistical significance. Results: Among 2157 randomized participants (mean age, 74.9 years; 61.7% women), 1900 (88%) completed the study. Median follow-up was 2.99 years. Overall, there were no statistically significant benefits of any intervention individually or in combination for the 6 end points at 3 years. For instance, the differences in mean change in systolic BP with vitamin D vs no vitamin D and with omega-3s vs no omega-3s were both -0.8 (99% CI, -2.1 to 0.5) mm Hg, with P < .13 and P < .11, respectively; the difference in mean change in diastolic BP with omega-3s vs no omega-3s was -0.5 (99% CI, -1.2 to 0.2) mm Hg; P = .06); and the difference in mean change in IR of infections with omega-3s vs no omega-3s was -0.13 (99% CI, -0.23 to -0.03), with an IR ratio of 0.89 (99% CI, 0.78-1.01; P = .02). No effects were found on the outcomes of SPPB, MoCA, and incidence of nonvertebral fractures). A total of 25 deaths were reported, with similar numbers in all treatment groups. Conclusions and Relevance: Among adults without major comorbidities aged 70 years or older, treatment with vitamin D3, omega-3s, or a strength-training exercise program did not result in statistically significant differences in improvement in systolic or diastolic blood pressure, nonvertebral fractures, physical performance, infection rates, or cognitive function. These findings do not support the effectiveness of these 3 interventions for these clinical outcomes. Trial Registration: ClinicalTrials.gov Identifier: NCT01745263.
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: JoAnn E Manson; Nancy R Cook; I-Min Lee; William Christen; Shari S Bassuk; Samia Mora; Heike Gibson; Christine M Albert; David Gordon; Trisha Copeland; Denise D'Agostino; Georgina Friedenberg; Claire Ridge; Vadim Bubes; Edward L Giovannucci; Walter C Willett; Julie E Buring Journal: N Engl J Med Date: 2018-11-10 Impact factor: 91.245
Authors: Heike A Bischoff-Ferrari; Walter C Willett; Endel J Orav; Endel J Oray; Paul Lips; Pierre J Meunier; Ronan A Lyons; Leon Flicker; John Wark; Rebecca D Jackson; Jane A Cauley; Haakon E Meyer; Michael Pfeifer; Kerrie M Sanders; Hannes B Stähelin; Robert Theiler; Bess Dawson-Hughes Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Yan Chun Li; Guilin Qiao; Milan Uskokovic; Wei Xiang; Wei Zheng; Juan Kong Journal: J Steroid Biochem Mol Biol Date: 2004-05 Impact factor: 4.292
Authors: Heike A Bischoff-Ferrari; Caroline de Godoi Rezende Costa Molino; Sandrine Rival; Bruno Vellas; René Rizzoli; Reto W Kressig; John A Kanis; JoAnn E Manson; Bess Dawson-Hughes; Endel J Orav; José A P da Silva; Michael Blauth; Dieter Felsenberg; Stephen M Ferrari; Robert Theiler; Andreas Egli Journal: Contemp Clin Trials Date: 2020-08-26 Impact factor: 2.226
Authors: A M Wolf; D J Hunter; G A Colditz; J E Manson; M J Stampfer; K A Corsano; B Rosner; A Kriska; W C Willett Journal: Int J Epidemiol Date: 1994-10 Impact factor: 7.196
Authors: Caoileann H Murphy; Ellen M Flanagan; Giuseppe De Vito; Davide Susta; Kathleen A J Mitchelson; Elena de Marco Castro; Joan M G Senden; Joy P B Goessens; Agnieszka Mikłosz; Adrian Chabowski; Ricardo Segurado; Clare A Corish; Sinead N McCarthy; Brendan Egan; Luc J C van Loon; Helen M Roche Journal: Am J Clin Nutr Date: 2021-06-01 Impact factor: 7.045
Authors: Payam Sharifan; Elahe Hassanzadeh; Maryam Mohammadi-Bajgiran; Vahid Reza Dabbagh; Elham Aminifar; Hamideh Ghazizadeh; Sara Saffar-Soflaei; Susan Darroudi; Davoud Tanbakouchi; Mohammad Reza Fazl-Mashhadi; Ali Ebrahimi-Dabagh; Mohammad Amin Mohammadi; Anahid Hemmatpur; Gordon A Ferns; Habibollah Esmaily; Ramin Sadeghi; Majid Ghayour-Mobarhan Journal: Arch Bone Jt Surg Date: 2022-07
Authors: L Vandenput; H Johansson; E V McCloskey; E Liu; K E Åkesson; F A Anderson; R Azagra; C L Bager; C Beaudart; H A Bischoff-Ferrari; E Biver; O Bruyère; J A Cauley; J R Center; R Chapurlat; C Christiansen; C Cooper; C J Crandall; S R Cummings; J A P da Silva; B Dawson-Hughes; A Diez-Perez; A B Dufour; J A Eisman; P J M Elders; S Ferrari; Y Fujita; S Fujiwara; C-C Glüer; I Goldshtein; D Goltzman; V Gudnason; J Hall; D Hans; M Hoff; R J Hollick; M Huisman; M Iki; S Ish-Shalom; G Jones; M K Karlsson; S Khosla; D P Kiel; W-P Koh; F Koromani; M A Kotowicz; H Kröger; T Kwok; O Lamy; A Langhammer; B Larijani; K Lippuner; D Mellström; T Merlijn; A Nordström; P Nordström; T W O'Neill; B Obermayer-Pietsch; C Ohlsson; E S Orwoll; J A Pasco; F Rivadeneira; B Schei; A-M Schott; E J Shiroma; K Siggeirsdottir; E M Simonsick; E Sornay-Rendu; R Sund; K M A Swart; P Szulc; J Tamaki; D J Torgerson; N M van Schoor; T P van Staa; J Vila; N J Wareham; N C Wright; N Yoshimura; M C Zillikens; M Zwart; N C Harvey; M Lorentzon; W D Leslie; J A Kanis Journal: Osteoporos Int Date: 2022-05-31 Impact factor: 5.071
Authors: Michelle Shardell; Anne R Cappola; Jack M Guralnik; Gregory E Hicks; Stephen B Kritchevsky; Eleanor M Simonsick; Luigi Ferrucci; Richard D Semba; Nancy Chiles Shaffer; Tamara Harris; Gudny Eiriksdottir; Vilmundur Gudnason; Mary Frances Cotch; Eric Orwoll; Kristine E Ensrud; Peggy M Cawthon Journal: Am J Clin Nutr Date: 2021-07-01 Impact factor: 7.045
Authors: Ian H de Boer; David K Prince; Kayleen Williams; Norrina B Allen; Gregory L Burke; Andrew N Hoofnagle; Simon Hsu; Xiaohui Li; Kiang J Liu; Robyn L McClelland; Erin D Michos; Bruce M Psaty; Steven J Shea; Kenneth M Rice; Jerome I Rotter; David S Siscovick; Russell P Tracy; Karol E Watson; Bryan R Kestenbaum Journal: Contemp Clin Trials Date: 2021-02-12 Impact factor: 2.226
Authors: Zahra Raisi-Estabragh; Adrian R Martineau; Elizabeth M Curtis; Rebecca J Moon; Andrea Darling; Susan Lanham-New; Kate A Ward; Cyrus Cooper; Patricia B Munroe; Steffen E Petersen; Nicholas C Harvey Journal: Aging Clin Exp Res Date: 2021-06-12 Impact factor: 3.636